Pandameds.com, a prescription referral service that connects patients in the United States with a licensed Canadian pharmacy network, said it has expanded access to generic semaglutide referrals for patients in all 50 states. The service works only for patients who have a valid prescription.
The move follows a series of regulatory decisions in Canada. In 2026, Canada became the first G7 country to approve a generic version of semaglutide, the active ingredient in Ozempic and Wegovy. Health Canada has since authorized additional generic versions, including the first approved for weight loss, and is reviewing several more submissions, according to the Government of Canada.
No FDA-approved generic semaglutide is available in the United States yet. The US patent on semaglutide runs until December 2031, and because the drug is a biologic that requires a biosimilar rather than a conventional generic, an approved US version is not expected until around 2033. That timing is part of why some US patients look to Canadian pharmacies for lower-cost options.
Under the US Food and Drug Administration's personal importation policy, an individual may generally bring in up to a 90-day supply of a non-controlled medication for personal use when they have a valid prescription. The FDA describes this as enforcement discretion rather than a guaranteed right, and the conditions can vary, so patients are advised to confirm their own eligibility and consult their prescriber. Patients who want the detail can read Pandameds.com explainer on whether Americans can legally buy prescription drugs from Canada: https://pandameds.com/blog/can-americans-legally-buy-prescription-drugs-from-canada/
Legislation before Congress, the Safe and Affordable Drugs from Canada Act of 2025, would set formal rules for importing from approved Canadian pharmacies.
Demand for GLP-1 medicines has grown sharply. About one in eight US adults say they are currently taking a GLP-1 drug for weight loss, diabetes or another condition, according to polling by KFF, and about half of the people who have used the drugs said the cost was hard to afford. Through the referral service, generic semaglutide is listed at about $200 a month, compared with a US list price of roughly $935 for the branded equivalent. US list prices vary with insurance coverage and manufacturer savings programs.
The service ships to all 50 states, including Alaska and Hawaii, with tracked delivery and temperature-controlled packaging for medications that need it. A valid US prescription is required on every order. General information about generic semaglutide is available in the company's resource on what patients should know about generic semaglutide: https://pandameds.com/blog/is-generic-semaglutide-safe/